MarkWittmanMDMBA, MPH

Anesthesiology • Beverly Hills, CA

Critical Care Medicine

Associate Professor of Anesthesia and Critical Care Medicine Loma Linda University Medical Center

Join to view full profile

Dr. Wittman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wittman's full profile

Already have an account?

Office
120 S Spalding Dr
Ste 301
Beverly Hills, CA 90212
Phone+1 310-385-7755

Fax+1 562-494-5623

Education & Training

UCLAMPH, 1995 - 1997
University of Southern CaliforniaMBA, 1992 - 1994
Cedars-Sinai Medical CenterResidency, Anesthesiology, 1986 - 1988
Massachusetts General HospitalResidency, Anesthesiology, 1984 - 1986
UCLA David Geffen School of Medicine/UCLA Medical Center/Olive ViewResidency, Emergency Medicine, 1981 - 1983
Michael Reese Hospital and Medical CenterInternship, Emergency Medicine, 1980 - 1981
Northwestern University The Feinberg School of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1981 - 2024
American Board of Anesthesiology Anesthesiology
American Board of Anesthesiology Critical Care Medicine

Publications & Presentations

PubMed

99 citations
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.
Mark D. Wittman, Joan M. Carboni, Ricardo M. Attar, Balu Balasubramanian, Praveen Balimane
Journal of Medicinal Chemistry. 2005-08-06

Industry Relationships

Consultant, Edwards LifesciencesAsia Pacific2009 - Present